Article
Cervical cancer screening: Impact of collection technique on human papillomavirus detection and genotyping
18 Jan 2025
Abstract excerpt
Background: The Food and Drug Administration (FDA) in the US approved primary human papillomavirus (HPV) testing for speculum-based cervical cancer screening ten years ago and, in May 2024, approved the self-collection technique. Our study defines the kappa agreement between self- and speculum-based collection techniques for 15 types of high-risk HPV. Additionally, we describe the sensitivity and specificity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
